Author Correction: Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies

Dami A. Collier, Anna Marco, Isabella A. T. M. Ferreira, Bo Meng, Rawlings P. Datir, Alexandra C. Walls, Steven A. Kemp, Jessica Bassi, Dora Pinto, Chiara Silacci-Fregni, Siro Bianchi, M. Alejandra Tortorici, John Bowen, Katja Culap, Stefano Jaconi, Elisabetta Cameroni, Gyorgy Snell, Matteo S. Pizzuto, Alessandra Franzetti Pellanda, Christian Garzoni, Agostino Riva, Anne Elmer, Nathalie Kingston, Barbara Graves, Laura E. McCoy, Kenneth G. C. Smith, John R. Bradley, Nigel Temperton, Lourdes Ceron-Gutierrez, Gabriela Barcenas-Morales, William Harvey, Herbert W. Virgin, Antonio Lanzavecchia, Luca Piccoli, Rainer Doffinger, Mark Wills, David Veesler, Davide Corti () and Ravindra K. Gupta ()
Additional contact information
Dami A. Collier: Cambridge Institute of Therapeutic Immunology & Infectious Disease
Anna Marco: Humabs Biomed SA, a subsidiary of Vir Biotechnology
Isabella A. T. M. Ferreira: Cambridge Institute of Therapeutic Immunology & Infectious Disease
Bo Meng: Cambridge Institute of Therapeutic Immunology & Infectious Disease
Rawlings P. Datir: Cambridge Institute of Therapeutic Immunology & Infectious Disease
Alexandra C. Walls: University of Washington
Steven A. Kemp: Cambridge Institute of Therapeutic Immunology & Infectious Disease
Jessica Bassi: Humabs Biomed SA, a subsidiary of Vir Biotechnology
Dora Pinto: Humabs Biomed SA, a subsidiary of Vir Biotechnology
Chiara Silacci-Fregni: Humabs Biomed SA, a subsidiary of Vir Biotechnology
Siro Bianchi: Humabs Biomed SA, a subsidiary of Vir Biotechnology
M. Alejandra Tortorici: University of Washington
John Bowen: University of Washington
Katja Culap: Humabs Biomed SA, a subsidiary of Vir Biotechnology
Stefano Jaconi: Humabs Biomed SA, a subsidiary of Vir Biotechnology
Elisabetta Cameroni: Humabs Biomed SA, a subsidiary of Vir Biotechnology
Gyorgy Snell: Vir Biotechnology
Matteo S. Pizzuto: Humabs Biomed SA, a subsidiary of Vir Biotechnology
Alessandra Franzetti Pellanda: Clinica Luganese Moncucco
Christian Garzoni: Clinica Luganese Moncucco
Agostino Riva: University of Milan
Anne Elmer: NIHR Cambridge Clinical Research Facility
Nathalie Kingston: NIHR Bioresource
Barbara Graves: NIHR Bioresource
Laura E. McCoy: University College London
Kenneth G. C. Smith: Cambridge Institute of Therapeutic Immunology & Infectious Disease
John R. Bradley: University of Cambridge
Nigel Temperton: University of Kent
Lourdes Ceron-Gutierrez: Addenbrooke’s Hospital
Gabriela Barcenas-Morales: Addenbrooke’s Hospital
William Harvey: University of Glasgow
Herbert W. Virgin: Vir Biotechnology
Antonio Lanzavecchia: Humabs Biomed SA, a subsidiary of Vir Biotechnology
Luca Piccoli: Humabs Biomed SA, a subsidiary of Vir Biotechnology
Rainer Doffinger: Addenbrooke’s Hospital
Mark Wills: University of Cambridge
David Veesler: University of Washington
Davide Corti: Humabs Biomed SA, a subsidiary of Vir Biotechnology
Ravindra K. Gupta: Cambridge Institute of Therapeutic Immunology & Infectious Disease

Nature, 2022, vol. 608, issue 7922, E24-E24

Date: 2022
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41586-022-05103-3 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:608:y:2022:i:7922:d:10.1038_s41586-022-05103-3

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/s41586-022-05103-3

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().